Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1505 (LINC01505) is a member of the long intergenic non-coding RNA (lincRNA) class. These are RNA molecules longer than 200 nucleotides that do not code for proteins and do not overlap with protein-coding loci[3][7][9][1]. LincRNAs are known to regulate gene expression through a variety of mechanisms, including remodeling chromatin, stabilizing RNA, and acting as transcriptional regulators[3][7]. A subset, including LINC01505, may have tissue-specific roles in fine-tuning gene expression[3][7][1]. While LINC01505 itself is not currently recognized as a directly druggable therapeutic target, similar lincRNAs have increasingly been implicated in cancer biology and resistance to infection, and studies indicate that LINC01505 may interact with SARS-CoV-2 and associated viral RNAs, suggesting a potential role in infection-related pathways[4]. No small molecules, drugs, or clinical biomarkers have been identified that directly target LINC01505 to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1505 (LINC01505).